111 related articles for article (PubMed ID: 26942860)
1. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
[TBL] [Abstract][Full Text] [Related]
2. Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
Rooney L; Vidal A; D'Souza AM; Devereux N; Masick B; Boissel V; West R; Head V; Stringer R; Lao J; Petrus MJ; Patapoutian A; Nash M; Stoakley N; Panesar M; Verkuyl JM; Schumacher AM; Petrassi HM; Tully DC
J Med Chem; 2014 Jun; 57(12):5129-40. PubMed ID: 24884675
[TBL] [Abstract][Full Text] [Related]
3. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
[TBL] [Abstract][Full Text] [Related]
4. Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation.
Lee KJ; Wang W; Padaki R; Bi V; Plewa CA; Gavva NR
J Pharmacol Exp Ther; 2014 Aug; 350(2):223-31. PubMed ID: 24893987
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
[TBL] [Abstract][Full Text] [Related]
6. α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists.
Verma VA; Shore DGM; Chen H; Chen J; Do S; Hackos DH; Kolesnikov A; Lyssikatos JP; Tay S; Wang L; Estrada AA
Bioorg Med Chem Lett; 2016 Jan; 26(2):495-498. PubMed ID: 26706172
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
Laliberté S; Vallée F; Fournier PA; Bedard L; Labrecque J; Albert JS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3204-6. PubMed ID: 24880903
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists.
Hu YJ; St-Onge M; Laliberté S; Vallée F; Jin S; Bedard L; Labrecque J; Albert JS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3199-203. PubMed ID: 24835202
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrofuran-Based Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists: Ligand-Based Discovery, Activity in a Rodent Asthma Model, and Mechanism-of-Action via Cryogenic Electron Microscopy.
Terrett JA; Chen H; Shore DG; Villemure E; Larouche-Gauthier R; Déry M; Beaumier F; Constantineau-Forget L; Grand-Maître C; Lépissier L; Ciblat S; Sturino C; Chen Y; Hu B; Lu A; Wang Y; Cridland AP; Ward SI; Hackos DH; Reese RM; Shields SD; Chen J; Balestrini A; Riol-Blanco L; Lee WP; Liu J; Suto E; Wu X; Zhang J; Ly JQ; La H; Johnson K; Baumgardner M; Chou KJ; Rohou A; Rougé L; Safina BS; Magnuson S; Volgraf M
J Med Chem; 2021 Apr; 64(7):3843-3869. PubMed ID: 33749283
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human transient receptor potential M5 upregulates endogenous human transient receptor potential A1 in a stable HEK cell line.
Buber MT; Cerne R; Cortés RY; Bryant RW; Lee SP
Assay Drug Dev Technol; 2010 Dec; 8(6):695-702. PubMed ID: 21133676
[TBL] [Abstract][Full Text] [Related]
11. Activation of transient receptor potential ankyrin 1 by eugenol.
Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
[TBL] [Abstract][Full Text] [Related]
12. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.
Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228
[TBL] [Abstract][Full Text] [Related]
13. Transient receptor potential ankyrin 1 (TRPA1) antagonists.
Preti D; Saponaro G; Szallasi A
Pharm Pat Anal; 2015; 4(2):75-94. PubMed ID: 25853468
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Potent (4 R,5 S)-4-Fluoro-5-methylproline Sulfonamide Transient Receptor Potential Ankyrin 1 Antagonist and Its Methylene Phosphate Prodrug Guided by Molecular Modeling.
Chen H; Volgraf M; Do S; Kolesnikov A; Shore DG; Verma VA; Villemure E; Wang L; Chen Y; Hu B; Lu AJ; Wu G; Xu X; Yuen PW; Zhang Y; Erickson SD; Dahl M; Brotherton-Pleiss C; Tay S; Ly JQ; Murray LJ; Chen J; Amm D; Lange W; Hackos DH; Reese RM; Shields SD; Lyssikatos JP; Safina BS; Estrada AA
J Med Chem; 2018 Apr; 61(8):3641-3659. PubMed ID: 29590749
[TBL] [Abstract][Full Text] [Related]
15. Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.
Culshaw AJ; Bevan S; Christiansen M; Copp P; Davis A; Davis C; Dyson A; Dziadulewicz EK; Edwards L; Eggelte H; Fox A; Gentry C; Groarke A; Hallett A; Hart TW; Hughes GA; Knights S; Kotsonis P; Lee W; Lyothier I; McBryde A; McIntyre P; Paloumbis G; Panesar M; Patel S; Seiler MP; Yaqoob M; Zimmermann K
J Med Chem; 2006 Jan; 49(2):471-4. PubMed ID: 16420034
[TBL] [Abstract][Full Text] [Related]
16. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
[TBL] [Abstract][Full Text] [Related]
17. Lipoic-based TRPA1/TRPV1 antagonist to treat orofacial pain.
Gualdani R; Ceruti S; Magni G; Merli D; Di Cesare Mannelli L; Francesconi O; Richichi B; la Marca G; Ghelardini C; Moncelli MR; Nativi C
ACS Chem Neurosci; 2015 Mar; 6(3):380-5. PubMed ID: 25546551
[TBL] [Abstract][Full Text] [Related]
18. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
[TBL] [Abstract][Full Text] [Related]
19. Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists.
Klionsky L; Tamir R; Gao B; Wang W; Immke DC; Nishimura N; Gavva NR
Mol Pain; 2007 Dec; 3():39. PubMed ID: 18086308
[TBL] [Abstract][Full Text] [Related]
20. Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonists.
Chen J; Lake MR; Sabet RS; Niforatos W; Pratt SD; Cassar SC; Xu J; Gopalakrishnan S; Pereda-Lopez A; Gopalakrishnan M; Holzman TF; Moreland RB; Walter KA; Faltynek CR; Warrior U; Scott VE
J Biomol Screen; 2007 Feb; 12(1):61-9. PubMed ID: 17099245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
